Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Groen

Showing results (431-440 of 456) with videos related to

Pageof 46
Sort By:
Leukemia|May 16, 2015
Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumabI S Nijhof, R W J Groen, H M Lokhorst, et al.
Blood|June 17, 2016
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myelomaInger S Nijhof, Tineke Casneuf, Jeroen van Velzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone diseaseAntonio Garcia-Gomez, Dalia Quwaider, Miriam Canavese, et al.
Nature Cancer|February 5, 2022
A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor responseRoeland Lameris, Adam Shahine, Daniel G Pellicci, et al.
Blood|October 14, 2016
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based nichesAntonella Antonelli, Willy A Noort, Jenny Jaques, et al.
The Lancet. Oncology|October 6, 2014
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screeningNanda Horeweg, Joost van Rosmalen, Marjolein A Heuvelmans, et al.
Blood|August 7, 2019
PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formationZhihong Ren, Jeong Hyun Ahn, Hequn Liu, et al.
NPJ Precision Oncology|January 28, 2025
A morphometric signature to identify ductal carcinoma in situ with a low risk of progressionMarcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, et al.
The Journal of Clinical Investigation|January 10, 2014
Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemiaAlejandro Gutierrez, Li Pan, Richard W J Groen, et al.
Annals of Surgical Oncology|December 2, 2020
Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort StudyAriane A van Loevezijn, Marieke E M van der Noordaa, Erik D van Werkhoven, et al.
Pageof 46

Showing results (431-440 of 456) with videos related to

Sort By:
Pageof 46
Leukemia|May 16, 2015
Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumabI S Nijhof, R W J Groen, H M Lokhorst, et al.
Blood|June 17, 2016
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myelomaInger S Nijhof, Tineke Casneuf, Jeroen van Velzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone diseaseAntonio Garcia-Gomez, Dalia Quwaider, Miriam Canavese, et al.
Nature Cancer|February 5, 2022
A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor responseRoeland Lameris, Adam Shahine, Daniel G Pellicci, et al.
Blood|October 14, 2016
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based nichesAntonella Antonelli, Willy A Noort, Jenny Jaques, et al.
The Lancet. Oncology|October 6, 2014
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screeningNanda Horeweg, Joost van Rosmalen, Marjolein A Heuvelmans, et al.
Blood|August 7, 2019
PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formationZhihong Ren, Jeong Hyun Ahn, Hequn Liu, et al.
NPJ Precision Oncology|January 28, 2025
A morphometric signature to identify ductal carcinoma in situ with a low risk of progressionMarcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, et al.
The Journal of Clinical Investigation|January 10, 2014
Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemiaAlejandro Gutierrez, Li Pan, Richard W J Groen, et al.
Annals of Surgical Oncology|December 2, 2020
Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort StudyAriane A van Loevezijn, Marieke E M van der Noordaa, Erik D van Werkhoven, et al.
Pageof 46